Edward Tenthoff
Stock Analyst at Piper Sandler
(4.27)
# 1,167
Out of 4,969 analysts
1267
Total ratings
40%
Success rate
7.8%
Average return
Main Sectors:
Stocks Rated by Edward Tenthoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARVN Arvinas | Reiterated: Buy | $20 | $8.40 | +138.10% | 34 | Sep 14, 2026 | |
| IBRX ImmunityBio | Reiterated: Buy | $12 | $8.37 | +43.37% | 8 | Sep 8, 2026 | |
| CAPR Capricor Therapeutics | Upgraded: Buy | $2 → $25 | $8.81 | +183.77% | 17 | Sep 1, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $489 | $249.99 | +95.61% | 101 | Aug 31, 2026 | |
| MESO Mesoblast | Reiterated: Buy | $35 → $39 | $15.02 | +159.65% | 16 | Aug 27, 2026 | |
| BMEA Biomea Fusion | Reiterated: Buy | $7 | $1.78 | +293.26% | 7 | Aug 14, 2026 | |
| CAMP Camp4 Therapeutics | Reiterated: Buy | $12 → $15 | $4.25 | +252.94% | 14 | Aug 14, 2026 | |
| FATE Fate Therapeutics | Reiterated: Buy | $6 → $8 | $2.34 | +242.61% | 38 | Aug 14, 2026 | |
| ACRV Acrivon Therapeutics | Reiterated: Buy | $8 | $1.96 | +308.16% | 6 | Aug 13, 2026 | |
| INO Inovio Pharmaceuticals | Reiterated: Buy | $4 | $1.18 | +238.98% | 9 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.31 | +358.02% | 7 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.20 | +275.00% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $16.00 | +50.00% | 3 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $13.90 | +166.19% | 19 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $77 | $146.69 | -47.51% | 112 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $24.53 | +34.53% | 47 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $126 | $80.67 | +56.19% | 75 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $52.96 | +107.70% | 67 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $7 | $1.60 | +337.50% | 9 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $47 | $18.52 | +153.78% | 25 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.56 | +92.31% | 30 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $64 | $18.53 | +245.39% | 23 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $6.64 | +125.90% | 25 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.00 | +100.00% | 21 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $23 → $3 | $3.79 | -20.84% | 20 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $7 | $0.9494 | +637.31% | 19 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $104 → $48 | $1.99 | +2,312.06% | 16 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $4.73 | +322.83% | 14 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 → $125 | $114.63 | +9.05% | 21 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $16.91 | +18.27% | 28 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $2 | $30.55 | n/a | 13 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $0.7843 | n/a | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $3.62 | n/a | 14 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.0004 | n/a | 20 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $3.89 | n/a | 14 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.5 | $18.10 | n/a | 4 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $13 | $0.3886 | n/a | 10 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $0.3 | $0.000001 | n/a | 6 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1 → $38 | $90.80 | n/a | 8 | Oct 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $44 | $15.62 | n/a | 3 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $13 | $1.82 | n/a | 14 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $60 | $16.30 | n/a | 15 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $323 | $519.51 | n/a | 49 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $9 | $1.17 | n/a | 9 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $40 | $72.45 | n/a | 17 | Aug 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $56.21 | n/a | 34 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $309 → $250 | $990.54 | n/a | 21 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $1.5 | $0.192 | n/a | 2 | Jun 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $2.5 | $1.17 | n/a | 5 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $70 → $90 | $146.41 | n/a | 3 | Mar 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.000001 | n/a | 4 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5 → $60 | $3.78 | n/a | 6 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $208 | $20.92 | n/a | 44 | Jun 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $14.27 | n/a | 1 | Jun 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $90 → $5 | $9.59 | n/a | 23 | Feb 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $0.00001 | n/a | 1 | Dec 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $19 | $39.60 | n/a | 5 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $0.1665 | n/a | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4 → $0.1 | $0.000001 | n/a | 8 | Mar 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $5 | $0.0001 | n/a | 9 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $557 | $793.74 | n/a | 35 | Sep 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $4 | $0.2811 | n/a | 6 | Feb 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $5.34 | n/a | 5 | Sep 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $79.80 | n/a | 1 | Aug 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1 | $0.000001 | n/a | 1 | Jul 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $20 | $51.44 | n/a | 1 | Jul 23, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $0.8127 | n/a | 1 | Mar 4, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.12 | n/a | 1 | Feb 20, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $2.5 | $11.73 | n/a | 1 | Dec 31, 2012 |
Arvinas
Sep 14, 2026
Reiterated: Buy
Price Target: $20
Current: $8.40
Upside: +138.10%
ImmunityBio
Sep 8, 2026
Reiterated: Buy
Price Target: $12
Current: $8.37
Upside: +43.37%
Capricor Therapeutics
Sep 1, 2026
Upgraded: Buy
Price Target: $2 → $25
Current: $8.81
Upside: +183.77%
Alnylam Pharmaceuticals
Aug 31, 2026
Reiterated: Buy
Price Target: $489
Current: $249.99
Upside: +95.61%
Mesoblast
Aug 27, 2026
Reiterated: Buy
Price Target: $35 → $39
Current: $15.02
Upside: +159.65%
Biomea Fusion
Aug 14, 2026
Reiterated: Buy
Price Target: $7
Current: $1.78
Upside: +293.26%
Camp4 Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $12 → $15
Current: $4.25
Upside: +252.94%
Fate Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $6 → $8
Current: $2.34
Upside: +242.61%
Acrivon Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $8
Current: $1.96
Upside: +308.16%
Inovio Pharmaceuticals
Aug 13, 2026
Reiterated: Buy
Price Target: $4
Current: $1.18
Upside: +238.98%
Aug 12, 2026
Reiterated: Buy
Price Target: $6
Current: $1.31
Upside: +358.02%
Aug 7, 2026
Reiterated: Buy
Price Target: $12
Current: $3.20
Upside: +275.00%
Aug 7, 2026
Reiterated: Buy
Price Target: $24
Current: $16.00
Upside: +50.00%
Aug 7, 2026
Reiterated: Buy
Price Target: $37
Current: $13.90
Upside: +166.19%
Aug 6, 2026
Reiterated: Buy
Price Target: $77
Current: $146.69
Upside: -47.51%
Aug 6, 2026
Reiterated: Buy
Price Target: $33
Current: $24.53
Upside: +34.53%
Aug 5, 2026
Reiterated: Buy
Price Target: $126
Current: $80.67
Upside: +56.19%
Aug 4, 2026
Reiterated: Buy
Price Target: $110
Current: $52.96
Upside: +107.70%
Jul 31, 2026
Reiterated: Buy
Price Target: $16 → $7
Current: $1.60
Upside: +337.50%
Jul 30, 2026
Reiterated: Buy
Price Target: $45 → $47
Current: $18.52
Upside: +153.78%
Jul 28, 2026
Reiterated: Buy
Price Target: $3
Current: $1.56
Upside: +92.31%
Jun 15, 2026
Reiterated: Buy
Price Target: $64
Current: $18.53
Upside: +245.39%
Jun 10, 2026
Reiterated: Buy
Price Target: $15
Current: $6.64
Upside: +125.90%
Jun 9, 2026
Reiterated: Buy
Price Target: $4
Current: $2.00
Upside: +100.00%
Jun 2, 2026
Downgraded: Sell
Price Target: $23 → $3
Current: $3.79
Upside: -20.84%
May 14, 2026
Reiterated: Buy
Price Target: $4 → $7
Current: $0.9494
Upside: +637.31%
May 12, 2026
Rated: Buy
Price Target: $104 → $48
Current: $1.99
Upside: +2,312.06%
Feb 13, 2026
Reiterated: Hold
Price Target: $20
Current: $4.73
Upside: +322.83%
Dec 9, 2025
Reiterated: Buy
Price Target: $98 → $125
Current: $114.63
Upside: +9.05%
Dec 4, 2025
Reiterated: Buy
Price Target: $20
Current: $16.91
Upside: +18.27%
Apr 1, 2025
Reiterated: Buy
Price Target: $3 → $2
Current: $30.55
Upside: n/a
Mar 28, 2025
Reiterated: Buy
Price Target: $65
Current: $0.7843
Upside: n/a
Feb 7, 2025
Reiterated: Buy
Price Target: $60
Current: $3.62
Upside: n/a
Oct 23, 2024
Reiterated: Buy
Price Target: $5
Current: $0.0004
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $52
Current: $3.89
Upside: n/a
Aug 17, 2023
Reiterated: Hold
Price Target: $0.5
Current: $18.10
Upside: n/a
Apr 11, 2023
Reiterated: Buy
Price Target: $9 → $13
Current: $0.3886
Upside: n/a
Feb 23, 2023
Downgraded: Hold
Price Target: $3 → $0.3
Current: $0.000001
Upside: n/a
Oct 27, 2022
Upgraded: Buy
Price Target: $1 → $38
Current: $90.80
Upside: n/a
Aug 25, 2022
Reiterated: Buy
Price Target: $37 → $44
Current: $15.62
Upside: n/a
Aug 12, 2022
Reiterated: Buy
Price Target: $20 → $13
Current: $1.82
Upside: n/a
May 23, 2022
Reiterated: Buy
Price Target: $160 → $60
Current: $16.30
Upside: n/a
Oct 18, 2021
Reiterated: Buy
Price Target: $323
Current: $519.51
Upside: n/a
Sep 20, 2021
Reiterated: Buy
Price Target: $7 → $9
Current: $1.17
Upside: n/a
Aug 8, 2021
Reiterated: Buy
Price Target: $42 → $40
Current: $72.45
Upside: n/a
Jun 28, 2021
Reiterated: Buy
Price Target: $36
Current: $56.21
Upside: n/a
Jun 7, 2021
Reiterated: Hold
Price Target: $309 → $250
Current: $990.54
Upside: n/a
Jun 30, 2020
Reiterated: Buy
Price Target: $3 → $1.5
Current: $0.192
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: $5 → $2.5
Current: $1.17
Upside: n/a
Mar 20, 2020
Upgraded: Buy
Price Target: $70 → $90
Current: $146.41
Upside: n/a
Dec 11, 2019
Reiterated: Buy
Price Target: $10
Current: $0.000001
Upside: n/a
Sep 5, 2019
Rated: Hold
Price Target: $5 → $60
Current: $3.78
Upside: n/a
Jun 21, 2019
Reiterated: Buy
Price Target: $200 → $208
Current: $20.92
Upside: n/a
Jun 4, 2019
Reiterated: Buy
Price Target: $32
Current: $14.27
Upside: n/a
Feb 28, 2019
Downgraded: Sell
Price Target: $90 → $5
Current: $9.59
Upside: n/a
Dec 12, 2018
Reiterated: Buy
Price Target: $30
Current: $0.00001
Upside: n/a
Nov 6, 2018
Reiterated: Buy
Price Target: $16 → $19
Current: $39.60
Upside: n/a
Oct 22, 2018
Initiated Coverage: Buy
Price Target: $23
Current: $0.1665
Upside: n/a
Mar 12, 2018
Downgraded: Sell
Price Target: $4 → $0.1
Current: $0.000001
Upside: n/a
Nov 2, 2017
Reiterated: Buy
Price Target: $17 → $5
Current: $0.0001
Upside: n/a
Sep 11, 2017
Reiterated: Buy
Price Target: $557
Current: $793.74
Upside: n/a
Feb 9, 2017
Reiterated: Buy
Price Target: $5 → $4
Current: $0.2811
Upside: n/a
Sep 7, 2016
Reiterated: Buy
Price Target: $1
Current: $5.34
Upside: n/a
Aug 18, 2016
Reiterated: Buy
Price Target: $35
Current: $79.80
Upside: n/a
Jul 9, 2015
Downgraded: Hold
Price Target: $1
Current: $0.000001
Upside: n/a
Jul 23, 2013
Downgraded: Sell
Price Target: $20
Current: $51.44
Upside: n/a
Mar 4, 2013
Rated: Buy
Price Target: $6
Current: $0.8127
Upside: n/a
Feb 20, 2013
Reiterated: Buy
Price Target: $6
Current: $1.12
Upside: n/a
Dec 31, 2012
Rated: Buy
Price Target: $2.5
Current: $11.73
Upside: n/a